Marcus Ståhlman

Sahlgrenska University Hospital — Sweden

Medicine · Health Sciences

57h-index13.8kcitations176works3.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(27), Adipose Tissue and Metabolism(26), Lipid metabolism and biosynthesis(23), Diet and metabolism studies(22), Drug Transport and Resistance Mechanisms(18)

Publications176 total

Gut microbial metabolite imidazole propionate impairs endothelial cell function and promotes the development of atherosclerosis
2024· 3 citedOpen Access
Supplementary Data from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Table S4 from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Data from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Supplementary Movie S1B from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Supplementary Data from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Supplementary Movie S1B from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Supplementary Movie S1C from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Data from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Table S4 from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Supplementary Movie S1A from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Supplementary Movie S1C from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Supplementary Movie S1A from Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
2023Open Access
Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2−/− mouse model of sclerosing cholangitis via immunomodulatory effects
Hepatology Communications·2022· 16 citedOpen Access
Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
Atherosclerosis Plus·2021· 3 citedOpen Access
Plasma Imidazole Propionate Is Positively Correlated with Blood Pressure in Overweight and Obese Humans
Nutrients·2021· 28 citedOpen Access
Correction to: Impairment of bile acid metabolism by perfluorooctanoic acid (PFOA) and perfluorooctanesulfonic acid (PFOS) in human HepaRG hepatoma cells
Archives of Toxicology·2021· 5 citedOpen Access
Treatment with HIV-Protease Inhibitor Nelfinavir Identifies Membrane Lipid Composition and Fluidity as a Therapeutic Target in Advanced Multiple Myeloma
Cancer Research·2021· 11 citedOpen Access
Feeding diversified protein sources exacerbates hepatic insulin resistance via increased gut microbial branched-chain fatty acids and mTORC1 signaling in obese mice
Nature Communications·2021· 106 citedOpen Access
Silencing of STE20‐type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet‐induced nonalcoholic fatty liver disease
The FASEB Journal·2021· 27 citedOpen Access
page 1 of 9Next →

Frequent Co-authors

Jan Borén(23), Fredrik Bäckhed(18), Hanns–Ulrich Marschall(9), Jens Nielsen(6), Annika Wahlström(6), Rosie Perkins(5), Martin Adiels(5), Marja‐Riitta Taskinen(5), Marc Pilon(5), Valentina Tremaroli(4), Petia Kovatcheva‐Datchary(4), Adil Mardinoğlu(4), Cheng Zhang(4), Mathias Uhlén(4), Kim Ekroos(4), Ulf Smith(4), Emma Svensk(4), Hao Wu(3), Muhammad Tanweer Khan(3), Max Nieuwdorp(3)